| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |